November 13, 2018
Rose
Athenahealth has rejected the hedge fund's attempts to push it into a sale previously. The all-cash deal between the companies values the medical billing software maker at $135 per share.
from Kaiser Health News https://ift.tt/2qIaPuf
November 13, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
How Reselling Unused Test Strips For Blood Glucose Is Driving An Unusual Trade Online And On The Streets- California’s Top Lawyer Cements His Role As Health Care Defender-In-Chief
- Rand Paul Will Undergo Surgery At Canadian Hospital–But He’ll Be Paying Out Of Pocket For The Procedure
- House Dems Open Investigation Into Pharma’s Drug Pricing Strategies, Calling The Probe One Of The Broadest In Decades
- First Edition: January 15, 2019
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment